Gregory Demopulos is the founder of Omeros. Latest round: IPO. Backed by BlackRock, Vanguard. Based in Seattle, USA.
Gregory Demopulos, M.D. is the President, CEO, Chairman, and founder of Omeros Corporation, a biopharmaceutical company focused on therapeutics for inflammation, immunologic diseases, and neurological disorders. He completed his orthopedic surgery residency at Stanford University and his hand and microvascular surgery fellowship at Duke University. Dr. Demopulos received both his M.D. and B.S. from Stanford University.
Full founder directory · Investor directory · Company funding database · Fundraising library